Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06M Sell
66,200
-6,900
-9% -$422K ﹤0.01% 2322
2026
Q1
$5.08M Sell
73,100
-32,200
-31% -$2.48M ﹤0.01% 1771
2025
Q4
$8.01M Buy
+105,300
New +$8.45M ﹤0.01% 1390
2025
Q3
Sell
-92,200
Closed -$6.29M 3581
2025
Q2
$6.29M Sell
92,200
-15,500
-14% -$960K ﹤0.01% 1252
2025
Q1
$6.41M Sell
107,700
-19,100
-15% -$1.21M ﹤0.01% 1094
2024
Q4
$7.67M Buy
126,800
+32,700
+35% +$2M ﹤0.01% 1044
2024
Q3
$6.78M Buy
94,100
+6,100
+7% +$426K ﹤0.01% 996
2024
Q2
$6.2M Buy
88,000
+63,900
+265% +$4.91M ﹤0.01% 976
2024
Q1
$1.92M Buy
+24,100
New +$1.94M ﹤0.01% 1381

Other funds holding APTV

IMC Chicago's APTV Position: Q2 2026 in Review

IMC Chicago increased its Aptiv (APTV) stake by 362% in Q2 2026, buying an estimated $2.88M and bringing the position to 60,141 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

IMC Chicago first reported a position in APTV in Q2 2024 and has held it in 4 quarters since. 661 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • IMC Chicago held 60,141 shares of Aptiv worth $3.69M as of Q2 2026.
  • IMC Chicago bought 47,115 Aptiv shares in Q2 2026, an estimated $2.88M.
  • Aptiv made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2421 holding.
  • IMC Chicago first reported a position in Aptiv in Q2 2024 and has held it in 4 quarters since.
  • 661 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.